| Symbol | HUM |
|---|---|
| Name | HUMANA INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Hospital & Medical Service Plans |
| Address | 101 E. MAIN STREET, LOUISVILLE, KY None |
| Telephone | 5025801000 |
| Fax | — |
| — | |
| Website | https://www.humana.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000049071 |
| Description | Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the militarys Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management. Additional info from NASDAQ: |
2026-06-24 14:45
New Form 11-K - HUMANA INC <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0000049071-26-000038 <b>Size:</b> 2 MB
Read more
2026-06-24 14:43
New Form 11-K - HUMANA INC <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0000049071-26-000037 <b>Size:</b> 3 MB
Read more
2026-06-23 16:00
Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales
Read more
2026-06-17 12:00
Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State
Read more
2026-06-16 11:00
Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients
Read more
2026-06-16 11:00
Humana, CenterWell y la National Hispanic Medical Association anuncian a los beneficiarios del Programa de Becas para Médicos Residentes de 2026
Read more
2026-06-15 17:38
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
Read more
2026-06-10 13:00
Humana and CenterWell Employees Donate More Than $1.4 Million in 24 Hours
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07365618 | Combined Exercise Effects in Breast Cancer-related Lymphedema | Na | Breast Cancer-Related Lymphedema | Not_Yet_Recruiting | 2026-04-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT07591818 | Effects of the Menstrual Cycle and Oral Contraceptive Use on Health and Perform… | — | Menstrual Cycle | Recruiting | 2026-04-01 | 2028-06-01 | ClinicalTrials.gov |
| NCT07349290 | Vitamin D (Bio)Fortified Shopping Baskets to Improve Vitamin D Status | Na | Vitamin D Biofortification | Enrolling_By_Invitation | 2026-02-12 | 2027-04-01 | ClinicalTrials.gov |
| NCT06782347 | Activating SilverSneakers Benefits for Seniors With Osteoarthritis | Na | Osteoarthritis | Recruiting | 2026-01-21 | 2028-07-01 | ClinicalTrials.gov |
| NCT07221890 | A Trial of Academic Detailing to Promote Prescribing of Biosimilars | Na | Autoimmune Diseases | Active_Not_Recruiting | 2025-11-06 | 2027-03-31 | ClinicalTrials.gov |
| NCT06919237 | Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescript… | Na | Coronary Arterial Disease (CAD) | Not_Yet_Recruiting | 2025-09-01 | 2028-06-01 | ClinicalTrials.gov |
| NCT07011459 | The Cooking for Health Optimization and Disease Prevention (CHOP) Trial | Na | Cardiovascular Diseases | Recruiting | 2025-07-07 | 2026-12-01 | ClinicalTrials.gov |
| NCT07021144 | VA|PREVENTION: Randomized Controlled Trial of a Person-Centred Digital Interven… | Na | Pre-diabetes | Active_Not_Recruiting | 2025-06-03 | 2026-11-25 | ClinicalTrials.gov |
| NCT06760663 | The Load-velocity Relationship: Neuromuscular Adaptations to Resistance Training | Na | Muscle Hypertrophy | Completed | 2025-03-03 | 2025-12-30 | ClinicalTrials.gov |
| NCT06732869 | Effectiveness of a Physical ACtivity Coaching Intervention Using E-Health for C… | Na | COPD | Recruiting | 2024-12-02 | 2025-06-01 | ClinicalTrials.gov |
| NCT06415370 | Food and Friends: Healthy Meals Delivered to You | Na | Mental Health Issue | Completed | 2024-08-14 | 2024-11-15 | ClinicalTrials.gov |
| NCT06368115 | A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer… | Na | Alzheimer Disease | Completed | 2024-07-01 | 2026-01-01 | ClinicalTrials.gov |
| NCT06390397 | Brighter Bites & University of Texas Physicians Produce Rx Extension: Evaluatin… | Na | Obesity, Childhood | Active_Not_Recruiting | 2024-04-22 | 2026-02-21 | ClinicalTrials.gov |
| NCT06128941 | Influence of Hypoxic, Normobaric and Hypobaric Training on the Immunometabolism… | Na | Normobaric Hypoxia | Unknown | 2024-01-03 | 2024-06-01 | ClinicalTrials.gov |
| NCT06136013 | Exercise Timing and the Circadian Clock in Individuals With Type 2 Diabetes and… | Na | Diabetes Mellitus, Type 2 | Unknown | 2024-01-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT06483438 | Handwriting as an Objective Tool to Support the Identification of People With A… | — | Dementia | Completed | 2023-12-02 | 2024-07-30 | ClinicalTrials.gov |
| NCT05926115 | Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia … | — | Polycystic Ovary Syndrome | Unknown | 2023-03-04 | 2023-09-30 | ClinicalTrials.gov |
| NCT06709560 | Baroreflex Sensitivity Response to Exercise | Na | Sex | Completed | 2023-01-02 | 2023-07-28 | ClinicalTrials.gov |
| NCT05297773 | Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvan… | Na | Breast Cancer | Completed | 2022-12-16 | 2025-12-30 | ClinicalTrials.gov |
| NCT05090501 | The Effects of High Intensity Circuit Training in Nature Vs. Indoor on Exercise… | Na | Green Exercise | Completed | 2022-10-15 | 2024-01-20 | ClinicalTrials.gov |
| NCT05147428 | A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer… | Na | Alzheimer Disease | Completed | 2022-06-01 | 2023-10-01 | ClinicalTrials.gov |
| NCT05860621 | Promoting Physical Activity in Breast Cancer Survivors on Aromatase Inhibitors | Na | Breast Cancer Female | Unknown | 2022-01-05 | 2025-02-01 | ClinicalTrials.gov |
| NCT07105410 | Hypoalgesic Effects of Exercise and Training of Different Modalities | Na | Training | Completed | 2022-01-01 | 2025-05-30 | ClinicalTrials.gov |
| NCT05380089 | Effects of Hydration Changes on Neuromuscular Function of Athletes | Na | Dehydration | Recruiting | 2021-11-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT06098794 | Effect of Sodium Bicarbonate on Exercise Performance | Na | Sodium Bicarbonate | Completed | 2021-10-15 | 2022-04-27 | ClinicalTrials.gov |
| NCT04862858 | Educational Intervention to Increase Select Guideline-recommended Cardioprotect… | Na | Diabetes Mellitus, Type 2 | Unknown | 2021-08-18 | 2022-08-16 | ClinicalTrials.gov |
| NCT05161429 | BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes | — | Diabetes Mellitus, Type 2 | Unknown | 2021-07-01 | 2024-06-30 | ClinicalTrials.gov |
| NCT05701943 | Comparison of Home- vs. Gym-based Exercise Delivery Modes | Na | Vascular Stiffness | Completed | 2020-11-02 | 2021-07-30 | ClinicalTrials.gov |
| NCT03149536 | Pharmacogenetic Algorithm for Individualized Controlled Ovarian Stimulation | Na | Infertility | Unknown | 2020-11-01 | 2022-11-30 | ClinicalTrials.gov |
| NCT04963049 | Effects of Facemask on Cardiorespiratory Performance | Na | Facemask Impact on Cardiorespiratory Performance | Completed | 2020-10-25 | 2021-04-29 | ClinicalTrials.gov |
| NCT05173558 | Breaking of Sitting Time Prevents Lower Leg Swelling | Na | Edema Leg | Completed | 2020-03-01 | 2020-07-31 | ClinicalTrials.gov |
| NCT05497999 | Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing | Na | Chronic Obstructive Pulmonary Disease | Completed | 2020-01-07 | 2022-12-31 | ClinicalTrials.gov |
| NCT06684912 | Acute Effects of Aerobic Exercise on Flow Mediated Slowing and Flow Mediated Di… | Na | Diabetes Mellitus, Type 2 | Completed | 2020-01-05 | 2022-01-15 | ClinicalTrials.gov |
| NCT04756635 | Effects of Short- Term Intermittent Fasting Aerobic and Anaerobic Capacity | Na | Healthy Males | Unknown | 2018-05-22 | 2023-02-05 | ClinicalTrials.gov |
| NCT03363100 | Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes -… | Na | Diabetes Mellitus, Type 2 | Completed | 2017-12-05 | 2019-02-23 | ClinicalTrials.gov |
| NCT03259373 | IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patie… | Na | Atrial Fibrillation | Completed | 2017-09-25 | 2021-12-31 | ClinicalTrials.gov |
| NCT03511092 | The Effects of Leucine Metabolites in Performance, Body Composition and Biochem… | Na | Resistance Training | Completed | 2017-05-29 | 2017-10-28 | ClinicalTrials.gov |
| NCT03092882 | Digital Self-Management Program for Medicare Advantage Members With Type 2 Diab… | Na | Diabetes Mellitus, Type 2 | Completed | 2017-03-03 | 2018-02-07 | ClinicalTrials.gov |
| NCT04495998 | The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia | Na | Psychomotor Status | Completed | 2017-01-01 | 2020-06-01 | ClinicalTrials.gov |
| NCT02697916 | Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term | Na | Atherosclerotic Cardiovascular Disease | Completed | 2016-04-01 | 2020-06-30 | ClinicalTrials.gov |
| NCT02358733 | Use of IMSI in Poor Responders to IVF | Na | Female Infertility | Terminated | 2015-02-01 | 2019-02-27 | ClinicalTrials.gov |
| NCT02746614 | Psychomotor Therapy Effects in Adaptive Behavior and Motor Proficiency in Intel… | Na | Intellectual Disability | Completed | 2014-09-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT03035721 | Clinical Evaluation of a Low Protein Content Formula in the First Months of Lif… | Na | Safety Issues | Completed | 2014-06-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02469402 | Nutritive Efficacy and Safety of a Modified Infant Formula With a Reduced Prote… | Na | Overweight | Completed | 2014-01-01 | 2016-12-31 | ClinicalTrials.gov |
| NCT01842178 | Endometrial Scratching in In Vitro Fertilization Cycles With Oocyte Donation | Na | Subfertility | Withdrawn | 2013-04-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT02190331 | Effects of a Resistance and Stretching Training Program on Forward Head and Pro… | Na | Posture Disorders in Children | Completed | 2012-10-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01603329 | Increasing Medication Adherence Through Physician Incentives and Messaging | Na | Medication Adherence | Completed | 2012-06-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01887652 | Individualization of Ovarian Stimulation Using AMH Maximizes the Benefits and M… | Na | Infertility | Completed | 2012-03-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT02037685 | Improving Adherence to Statins Among Minority Populations | Na | Dyslipidemia | Completed | 2010-06-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01651208 | Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations | Na | Coronary Artery Disease | Completed | 2010-01-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01110252 | Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease | Na | Chronic Obstructive Pulmonary Disease | Completed | 2009-05-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT03823898 | Lifestyle Intervention in Overweight Women | Na | Obesity | Completed | 2002-01-02 | 2003-12-01 | ClinicalTrials.gov |
Total clinical trials: 52
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Control group | Other | Approved | Breast Cancer | COMPLETED | NCT05297773 |
| Resistance Training Group | Other | Approved | Breast Cancer | COMPLETED | NCT05297773 |
| Aerobic Training Group | Other | Approved | Breast Cancer | COMPLETED | NCT05297773 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| individualized ovarian stimulation | Other | Approved | Infertility | COMPLETED | NCT01887652 |
| conventional ovarian stimulation | Other | Approved | Infertility | COMPLETED | NCT01887652 |
| individualized ovarian stimulation | Other | Approved | Infertility | COMPLETED | NCT01887652 |
| conventional ovarian stimulation | Other | Approved | Infertility | COMPLETED | NCT01887652 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Delayed Provider-Level Educational Intervention | Other | Approved | Atrial Fibrillation | COMPLETED | NCT03259373 |
| Early Patient-Level and Provider-Level Educational Intervention | Other | Approved | Atrial Fibrillation | COMPLETED | NCT03259373 |
| stem cells infusion | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT01110252 |
| stem cells collection | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT01110252 |
| Stem cells stimulation | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT01110252 |
| stem cells infusion | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT01110252 |
| stem cells collection | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT01110252 |
| Stem cells stimulation | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT01110252 |
| Control Group physical education classes | Other | Approved | Posture Disorders in Children | COMPLETED | NCT02190331 |
| Interventional program postural correction training | Other | Approved | Posture Disorders in Children | COMPLETED | NCT02190331 |
| Control Group physical education classes | Other | Approved | Posture Disorders in Children | COMPLETED | NCT02190331 |
| Interventional program postural correction training | Other | Approved | Posture Disorders in Children | COMPLETED | NCT02190331 |
| Increasing Medication Adherence through Physician Incentives and Messaging | Drug | Approved | Medication Adherence | COMPLETED | NCT01603329 |
| Usual Care | Other | Approved | Dyslipidemia | COMPLETED | NCT02037685 |
| Motivational Interviewing (MINT) | Other | Approved | Dyslipidemia | COMPLETED | NCT02037685 |
| Psychomotor Therapy | Drug | Approved | Intellectual Disability | COMPLETED | NCT02746614 |
| Psychomotor Therapy | Drug | Approved | Intellectual Disability | COMPLETED | NCT02746614 |
| scratching | Other | Approved | Subfertility | WITHDRAWN | NCT01842178 |
| scratching | Other | Approved | Subfertility | WITHDRAWN | NCT01842178 |
| Standard protein formula | Other | Approved | Safety Issues | COMPLETED | NCT03035721 |
| Low protein formula | Other | Approved | Safety Issues | COMPLETED | NCT03035721 |
| Standard protein formula | Other | Approved | Safety Issues | COMPLETED | NCT03035721 |
| Low protein formula | Other | Approved | Safety Issues | COMPLETED | NCT03035721 |
| Monthly behavioral sessions | Other | Approved | Obesity | COMPLETED | NCT03823898 |
| Lifestyle intervention from baseline to 4 months | Other | Approved | Obesity | COMPLETED | NCT03823898 |
| Supervised exercise | Other | Approved | Obesity | COMPLETED | NCT03823898 |
| Monthly behavioral sessions | Other | Approved | Obesity | COMPLETED | NCT03823898 |
| Lifestyle intervention from baseline to 4 months | Other | Approved | Obesity | COMPLETED | NCT03823898 |
| Supervised exercise | Other | Approved | Obesity | COMPLETED | NCT03823898 |
| Intra-cytoplasmic Morphologically-selected Sperm Injection | Other | Approved | Female Infertility | TERMINATED | NCT02358733 |
| Intra-cytoplasmic Sperm Injection | Other | Approved | Female Infertility | TERMINATED | NCT02358733 |
| Intra-cytoplasmic Morphologically-selected Sperm Injection | Other | Approved | Female Infertility | TERMINATED | NCT02358733 |
| Intra-cytoplasmic Sperm Injection | Other | Approved | Female Infertility | TERMINATED | NCT02358733 |
| Diabetes Self-Management Program | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03092882 |
| Diabetes Self-Management Program | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03092882 |
| Diabetes Self-Management Program | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03092882 |
| Digital health Partnership program | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03363100 |
| Digital health Partnership program | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03363100 |
| Digital health Partnership program | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03363100 |
| Protein reduced alpha-lactalbumin formula, with higher levels of alpha-lactalbumin | Other | Approved | Overweight | COMPLETED | NCT02469402 |
| Standard infant formula | Other | Approved | Overweight | COMPLETED | NCT02469402 |
| Pharmacogenetic test | Other | Approved | Infertility | UNKNOWN | NCT03149536 |
| Pharmacogenetic test | Other | Approved | Infertility | UNKNOWN | NCT03149536 |
| aspirin | Other | Approved | Atherosclerotic Cardiovascular Disease | COMPLETED | NCT02697916 |
| Protocol with Mask | Other | Approved | Facemask Impact on Cardiorespiratory Performance | COMPLETED | NCT04963049 |
| Protocol with Mask | Other | Approved | Facemask Impact on Cardiorespiratory Performance | COMPLETED | NCT04963049 |
| Sit-to-stand transitions | Other | Approved | Edema Leg | COMPLETED | NCT05173558 |
| Uninterrupted motionless sitting | Other | Approved | Edema Leg | COMPLETED | NCT05173558 |
| Uninterrupted motionless standing | Other | Approved | Edema Leg | COMPLETED | NCT05173558 |
| Sit-to-stand transitions | Other | Approved | Edema Leg | COMPLETED | NCT05173558 |
| Uninterrupted motionless sitting | Other | Approved | Edema Leg | COMPLETED | NCT05173558 |
| Uninterrupted motionless standing | Other | Approved | Edema Leg | COMPLETED | NCT05173558 |
| Educational Intervention | Other | Approved | Diabetes Mellitus, Type 2 | UNKNOWN | NCT04862858 |
| Experimental Group | Other | Approved | Healthy Males | UNKNOWN | NCT04756635 |
| Experimental Group | Other | Approved | Healthy Males | UNKNOWN | NCT04756635 |
| Gym-Based | Other | Approved | Vascular Stiffness | COMPLETED | NCT05701943 |
| Home-Based | Other | Approved | Vascular Stiffness | COMPLETED | NCT05701943 |
| Gym-Based | Other | Approved | Vascular Stiffness | COMPLETED | NCT05701943 |
| Home-Based | Other | Approved | Vascular Stiffness | COMPLETED | NCT05701943 |
| No Proactive Outreach | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT05497999 |
| Proactive Outreach | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT05497999 |
| No Proactive Outreach | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT05497999 |
| Proactive Outreach | Other | Approved | Chronic Obstructive Pulmonary Disease | COMPLETED | NCT05497999 |
| Structured Exercise Program | Other | Approved | Breast Cancer Female | UNKNOWN | NCT05860621 |
| Brief Physical Activity Counselling | Other | Approved | Breast Cancer Female | UNKNOWN | NCT05860621 |
| Structured Exercise Program | Other | Approved | Breast Cancer Female | UNKNOWN | NCT05860621 |
| Brief Physical Activity Counselling | Other | Approved | Breast Cancer Female | UNKNOWN | NCT05860621 |
| Brief Motor Scale_portuguese version (BMS_pt) | Other | Approved | Psychomotor Status | COMPLETED | NCT04495998 |
| Brief Motor Scale_portuguese version (BMS_pt) | Other | Approved | Psychomotor Status | COMPLETED | NCT04495998 |
| SLGT2 | Other | Preclinical | Diabetes Mellitus, Type 2 | UNKNOWN | NCT05161429 |
| Basal Insulin | Other | Preclinical | Diabetes Mellitus, Type 2 | UNKNOWN | NCT05161429 |
| GLP-1 receptor agonist | Other | Preclinical | Diabetes Mellitus, Type 2 | UNKNOWN | NCT05161429 |
| DPP4 | Other | Preclinical | Diabetes Mellitus, Type 2 | UNKNOWN | NCT05161429 |
| Venous puncture | Other | Preclinical | Polycystic Ovary Syndrome | UNKNOWN | NCT05926115 |
| Diagnostic Ultrasound | Other | Preclinical | Polycystic Ovary Syndrome | UNKNOWN | NCT05926115 |
| Venous puncture | Other | Preclinical | Polycystic Ovary Syndrome | UNKNOWN | NCT05926115 |
| Diagnostic Ultrasound | Other | Preclinical | Polycystic Ovary Syndrome | UNKNOWN | NCT05926115 |
| Placebo | Other | Approved | Sodium Bicarbonate | COMPLETED | NCT06098794 |
| Sodium Bicarbonate | Other | Approved | Sodium Bicarbonate | COMPLETED | NCT06098794 |
| Placebo | Other | Approved | Sodium Bicarbonate | COMPLETED | NCT06098794 |
| Sodium Bicarbonate | Other | Approved | Sodium Bicarbonate | COMPLETED | NCT06098794 |
| HIIT | Other | Approved | Diabetes Mellitus, Type 2 | UNKNOWN | NCT06136013 |
| HIIT | Other | Approved | Diabetes Mellitus, Type 2 | UNKNOWN | NCT06136013 |
| Mailed DVD | Other | Approved | Coronary Artery Disease | COMPLETED | NCT01651208 |
| Motivational Interviewing (MINT) | Other | Approved | Coronary Artery Disease | COMPLETED | NCT01651208 |
| Repeated sprint | Other | Approved | Normobaric Hypoxia | UNKNOWN | NCT06128941 |
| Repeated sprint | Other | Approved | Normobaric Hypoxia | UNKNOWN | NCT06128941 |
| Placebo comparator | Other | Approved | Resistance Training | COMPLETED | NCT03511092 |
| alfa-HICA | Other | Approved | Resistance Training | COMPLETED | NCT03511092 |
| HMB-Ca | Other | Approved | Resistance Training | COMPLETED | NCT03511092 |
| HMB-FA | Other | Approved | Resistance Training | COMPLETED | NCT03511092 |
| Placebo comparator | Other | Approved | Resistance Training | COMPLETED | NCT03511092 |
| alfa-HICA | Other | Approved | Resistance Training | COMPLETED | NCT03511092 |
| HMB-Ca | Other | Approved | Resistance Training | COMPLETED | NCT03511092 |
| HMB-FA | Other | Approved | Resistance Training | COMPLETED | NCT03511092 |
| High Intensity Circuit Training | Other | Approved | Green Exercise | COMPLETED | NCT05090501 |
| High Intensity Circuit Training | Other | Approved | Green Exercise | COMPLETED | NCT05090501 |
| Increasing water intake | Other | Approved | Dehydration | RECRUITING | NCT05380089 |
| Increasing water intake | Other | Approved | Dehydration | RECRUITING | NCT05380089 |
| Moderate continuous exercise | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT06684912 |
| High-intensity interval exercise | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT06684912 |
| Moderate continuous exercise | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT06684912 |
| High-intensity interval exercise | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT06684912 |
| Educational Materials | Other | Approved | Alzheimer Disease | COMPLETED | NCT05147428 |
| Educational Materials | Other | Approved | Alzheimer Disease | COMPLETED | NCT05147428 |
| Vigorous Intensity Continuous Exercise Matched for Blood Pressure | Other | Approved | Sex | COMPLETED | NCT06709560 |
| Moderate Intensity Continuous Exercise Matched for Blood Pressure | Other | Approved | Sex | COMPLETED | NCT06709560 |
| Vigorous Intensity Continuous Exercise | Other | Approved | Sex | COMPLETED | NCT06709560 |
| Moderate Intensity Continuous Exercise | Other | Approved | Sex | COMPLETED | NCT06709560 |
| Vigorous Intensity Continuous Exercise Matched for Blood Pressure | Other | Approved | Sex | COMPLETED | NCT06709560 |
| Moderate Intensity Continuous Exercise Matched for Blood Pressure | Other | Approved | Sex | COMPLETED | NCT06709560 |
| Vigorous Intensity Continuous Exercise | Other | Approved | Sex | COMPLETED | NCT06709560 |
| Moderate Intensity Continuous Exercise | Other | Approved | Sex | COMPLETED | NCT06709560 |
| pulmonary rehabilitation | Other | Approved | COPD | RECRUITING | NCT06732869 |
| eHealth physical activity coaching intervention | Other | Approved | COPD | RECRUITING | NCT06732869 |
| pulmonary rehabilitation | Other | Approved | COPD | RECRUITING | NCT06732869 |
| eHealth physical activity coaching intervention | Other | Approved | COPD | RECRUITING | NCT06732869 |
| Student Companion calls | Other | Approved | Mental Health Issue | COMPLETED | NCT06415370 |
| In-person "friendly visits" | Other | Approved | Mental Health Issue | COMPLETED | NCT06415370 |
| Home Delivered Healthy Meals | Other | Approved | Mental Health Issue | COMPLETED | NCT06415370 |
| Control group | Other | Approved | Breast Cancer | RECRUITING | NCT05297773 |
| Resistance Training Group | Other | Approved | Breast Cancer | RECRUITING | NCT05297773 |
| Aerobic Training Group | Other | Approved | Breast Cancer | RECRUITING | NCT05297773 |
| Control group | Other | Approved | Breast Cancer | RECRUITING | NCT05297773 |
| Resistance Training Group | Other | Approved | Breast Cancer | RECRUITING | NCT05297773 |
| Aerobic Training Group | Other | Approved | Breast Cancer | RECRUITING | NCT05297773 |
| HRV-Guided Intervention | Other | Approved | Coronary Arterial Disease (CAD) | NOT_YET_RECRUITING | NCT06919237 |
| MICT Intervention | Other | Approved | Coronary Arterial Disease (CAD) | NOT_YET_RECRUITING | NCT06919237 |
| HIIT Intervention | Other | Approved | Coronary Arterial Disease (CAD) | NOT_YET_RECRUITING | NCT06919237 |
| HRV-Guided Intervention | Other | Approved | Coronary Arterial Disease (CAD) | NOT_YET_RECRUITING | NCT06919237 |
| MICT Intervention | Other | Approved | Coronary Arterial Disease (CAD) | NOT_YET_RECRUITING | NCT06919237 |
| HIIT Intervention | Other | Approved | Coronary Arterial Disease (CAD) | NOT_YET_RECRUITING | NCT06919237 |
| Standard of care | Other | Approved | Obesity, Childhood | ACTIVE_NOT_RECRUITING | NCT06390397 |
| Produce prescription program | Other | Approved | Obesity, Childhood | ACTIVE_NOT_RECRUITING | NCT06390397 |
| Standard of care | Other | Approved | Obesity, Childhood | ACTIVE_NOT_RECRUITING | NCT06390397 |
| Produce prescription program | Other | Approved | Obesity, Childhood | ACTIVE_NOT_RECRUITING | NCT06390397 |
| Aim #3: The hypoalgesic effects of chronic training of different modalities | Other | Approved | Training | COMPLETED | NCT07105410 |
| Aim #2: The hypoalgesic effects of acute exercise of different modalities | Other | Approved | Training | COMPLETED | NCT07105410 |
| Aim #1: The effect of post-exercise circulatory occlusion on H-reflex and V-wave | Other | Approved | Training | COMPLETED | NCT07105410 |
| Aim #3: The hypoalgesic effects of chronic training of different modalities | Other | Approved | Training | COMPLETED | NCT07105410 |
| Aim #2: The hypoalgesic effects of acute exercise of different modalities | Other | Approved | Training | COMPLETED | NCT07105410 |
| Aim #1: The effect of post-exercise circulatory occlusion on H-reflex and V-wave | Other | Approved | Training | COMPLETED | NCT07105410 |
| Standard of care | Other | Approved | Cardiovascular Diseases | RECRUITING | NCT07011459 |
| Cooking class | Other | Approved | Cardiovascular Diseases | RECRUITING | NCT07011459 |
| Type 2 Diabetes Guidebook | Other | Approved | Pre-diabetes | ACTIVE_NOT_RECRUITING | NCT07021144 |
| VA|PREVENTION web application (digital intervention) | Other | Approved | Pre-diabetes | ACTIVE_NOT_RECRUITING | NCT07021144 |
| Type 2 Diabetes Guidebook | Other | Approved | Pre-diabetes | ACTIVE_NOT_RECRUITING | NCT07021144 |
| VA|PREVENTION web application (digital intervention) | Other | Approved | Pre-diabetes | ACTIVE_NOT_RECRUITING | NCT07021144 |
| Standard-of-care outreach from the insurance plan | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| Offered an academic detailing session | Other | Approved | Autoimmune Diseases | ACTIVE_NOT_RECRUITING | NCT07221890 |
| The load-velocity relationship: Neuromuscular adaptations to resistance training | Other | Approved | Muscle Hypertrophy | COMPLETED | NCT06760663 |
| The load-velocity relationship: Neuromuscular adaptations to resistance training | Other | Approved | Muscle Hypertrophy | COMPLETED | NCT06760663 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Control food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Vitamin D (bio)fortified food basket | Other | Approved | Vitamin D Biofortification | ENROLLING_BY_INVITATION | NCT07349290 |
| Educational Sessions | Other | Approved | Breast Cancer-Related Lymphedema | NOT_YET_RECRUITING | NCT07365618 |
| Exercise | Other | Approved | Breast Cancer-Related Lymphedema | NOT_YET_RECRUITING | NCT07365618 |
| Educational Sessions | Other | Approved | Breast Cancer-Related Lymphedema | NOT_YET_RECRUITING | NCT07365618 |
| Exercise | Other | Approved | Breast Cancer-Related Lymphedema | NOT_YET_RECRUITING | NCT07365618 |
| Educational Sessions | Other | Approved | Breast Cancer-Related Lymphedema | NOT_YET_RECRUITING | NCT07365618 |
| Exercise | Other | Approved | Breast Cancer-Related Lymphedema | NOT_YET_RECRUITING | NCT07365618 |
| Proactive Care | Other | Approved | Osteoarthritis | RECRUITING | NCT06782347 |
| Educational Materials | Other | Approved | Alzheimer Disease | COMPLETED | NCT06368115 |
| Type 2 Diabetes Guidebook | BEHAVIORAL | Approved | Pre-diabetes | ACTIVE_NOT_RECRUITING | NCT07021144 |
| VA|PREVENTION web application (digital intervention) | BEHAVIORAL | Approved | Pre-diabetes | ACTIVE_NOT_RECRUITING | NCT07021144 |
| Delayed Provider-Level Educational Intervention | BEHAVIORAL | Approved | Atrial Fibrillation | COMPLETED | NCT03259373 |
| Early Patient-Level and Provider-Level Educational Intervention | BEHAVIORAL | Approved | Atrial Fibrillation | COMPLETED | NCT03259373 |
| aspirin | DRUG | Approved | Atherosclerotic Cardiovascular Disease | COMPLETED | NCT02697916 |
| Increasing Medication Adherence through Physician Incentives and Messaging | OTHER | Approved | Medication Adherence | COMPLETED | NCT01603329 |
Total products: 211